Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Accesswire
· *Announces next-generation COVID-19 vaccine candidate as fourth respiratory vaccine to successfully meet its Phase 3..
· *Announces next-generation COVID-19 vaccine candidate as fourth respiratory vaccine to successfully meet its Phase 3..
*Company's flu vaccine, mRNA-1010, met its primary endpoint in Phase 3 trial; separate Phase 1/2 data demonstrated higher HAI..
The "Dearly Discarded Podcast" features host Jared St. Clair engaging in a conversation with guest David Russell,..